Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy [Phase 2]
A Phase 2 clinical trial comparing ruxolitinib to prednisone as first-line systemic therapy for chronic graft-versus-host disease (cGVHD) is…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease [Phase 3]
A Phase 3 clinical trial is evaluating axatilimab plus corticosteroids as initial treatment for chronic graft-versus-host disease; the study…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) [Phase 2]
A Phase 2 clinical trial of belumosudil in children with chronic graft-versus-host disease is currently recruiting in the schoolROCK study.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease [NA]
This ClinicalTrials.gov entry notes an active, not recruiting study at Massachusetts General Hospital evaluating a tele-palliative care inte…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) [Phase 2]
This update reports a Phase 2 clinical trial investigating novel therapies for severe acute graft-versus-host disease, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention [Phase 2]
A Phase 2 clinical trial is evaluating low-dose post-transplant cyclophosphamide after allogeneic stem cell transplantation to prevent graft…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Endothelial Dysfunction as a Predictive Marker of Acute Graft-Versus-Host Disease in Adult Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
A completed clinical trial evaluated endothelial dysfunction as a predictive biomarker for acute graft-versus-host disease in adults undergo…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Evaluation of Patients With Immune Function Abnormalities
The NIAID-sponsored study evaluating patients with immune function abnormalities (chronic granulomatous disease, X-linked severe combined im…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating photobiomodulation therapy for oral graft-versus-host disease in patients after stem cell transplantation;…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Axatilimab for Sclerotic Chronic Graft-versus-Host Disease [Phase 2]
Phase 2 clinical trial update for Axatilimab in sclerotic chronic graft-versus-host disease. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]
Phase I/II clinical trial evaluating pacritinib, a JAK2/IRAK1/CSF1R inhibitor, in patients with refractory chronic graft-versus-host disease…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD [NA]
This clinical trial registry entry describes an ongoing study evaluating the safety and preliminary efficacy of iMesenchymal Stromal Cells (…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease [NA]
A clinical trial update on a digital health intervention aimed at improving quality of life for adults with chronic graft-versus-host diseas…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
An observational study sponsored by Incyte Corporation is enrolling patients at risk for chronic graft-versus-host disease (cGVHD) to observ…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: MAGIC Ruxolitinib for aGVHD [Phase 2]
Phase 2 clinical trial investigating ruxolitinib for acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplan…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy [Phase 3]
A Phase 3 clinical trial is evaluating Axatilimab for chronic graft-versus-host disease in participants who have received at least two prior…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of Axatilimab in combination with ruxolitinib for newly diagnosed chronic g…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Chronic GVHD Response Measures Validation
This clinical trial update validates measures used to assess response in chronic graft-versus-host disease.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation [Phase 1, Phase 2]
This Phase 1/2 trial is evaluating the lowest effective dose of post-transplant cyclophosphamide in combination with sirolimus and mycopheno…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: IL6-receptor Inhibitor Iwith Belumosudil for the Treatment of Belumosudil-refractory cGVHD [Phase 1]
A Phase 1 clinical trial update describes testing belumosudil in combination with an IL-6 receptor inhibitor for belumosudil-refractory chro…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Improvement of Women's Health After Allogeneic Stem Cell Transplantation
Clinical trial update indicating recruiting status for a study on improving women's health after allogeneic stem cell transplantation, with …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)
A clinical trial update for the PREDICT trial at Boston Children's Hospital, focusing on precision diagnostics in inflammatory bowel disease…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD [Phase 1]
Phase 1 trial evaluating ex vivo-expanded regulatory T cells plus low-dose interleukin-2 for steroid-refractory chronic graft-versus-host di…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD). [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating gecacitinib for steroid-refractory or dependent chronic graft-versus-host disease (cGVHD) in HSCT patien…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD. [Phase 1]
This document provides an update on a Phase 1 clinical trial evaluating AC-003 capsules for acute graft-versus-host disease, currently recru…